Michael A. Palladino
ORCID:0000-0002-4687-7612
发表论文 302 篇 · 总被引 22531 次 · h-index 70
代表论文
- Marizomib, a Proteasome Inhibitor for All Seasons: Preclinical Profile and a Framework for Clinical Trials (2011 · Current Cancer Drug Targets · 被引 245)
- Phase 1 clinical trial of the novel proteasome inhibitor marizomib with the histone deacetylase inhibitor vorinostat in patients with melanoma, pancreatic and lung cancer based on in vitro assessments of the combination (2011 · Investigational New Drugs · 被引 151)
- Synthesis and Structure–Activity Relationship Study of Antimicrotubule Agents Phenylahistin Derivatives with a Didehydropiperazine-2,5-dione Structure (2011 · Journal of Medicinal Chemistry · 被引 107)
- Randomized trial on adjuvant treatment with FOLFIRI followed by docetaxel and cisplatin versus 5-fluorouracil and folinic acid for radically resected gastric cancer (2014 · Annals of Oncology · 被引 91)
- A novel vascular disrupting agent plinabulin triggers JNK-mediated apoptosis and inhibits angiogenesis in multiple myeloma cells (2011 · Blood · 被引 84)
- Standards in semen examination: publishing reproducible and reliable data based on high-quality methodology (2022 · Human Reproduction · 被引 71)